These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8011411)

  • 1. No evidence to implicate Borrelia burgdorferi in the pathogenesis of dilated cardiomyopathy in the United Kingdom.
    Rees DH; Keeling PJ; McKenna WJ; Axford JS
    Br Heart J; 1994 May; 71(5):459-61. PubMed ID: 8011411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
    Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
    Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borrelia burgdorferi as an etiologic agent in chronic heart failure?
    Stanek G; Klein J; Bittner R; Glogar D
    Scand J Infect Dis Suppl; 1991; 77():85-7. PubMed ID: 1947816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No serological evidence for Borrelia burgdorferi sensu lato infection in patients with dilated cardiomyopathy in Northern France.
    N'Guyen Y; Lesaffre F; Metz D; de Martino S; Jaulhac B; Andréoletti L
    Infect Dis (Lond); 2016 Oct; 48(10):763-4. PubMed ID: 27329434
    [No Abstract]   [Full Text] [Related]  

  • 5. Lyme arthritis: oligoclonal anti-Borrelia burgdorferi IgG antibodies occur in joint fluid and serum.
    Cruz M; Hansen K; Ernerudh J; Steere AC; Link H
    Scand J Immunol; 1991 Jan; 33(1):61-71. PubMed ID: 1996408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease.
    Feder HM; Gerber MA; Luger SW; Ryan RW
    Clin Infect Dis; 1992 Nov; 15(5):788-93. PubMed ID: 1445977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
    Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme-linked immunosorbent assay, immunofluorescent assay, and recombinant immunoblotting in the serodiagnosis of early Lyme borreliosis.
    Christova I
    Int J Immunopathol Pharmacol; 2003; 16(3):261-8. PubMed ID: 14611730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligoclonal Borrelia burgdorferi-specific IgG antibodies in cerebrospinal fluid in Lyme neuroborreliosis.
    Hansen K; Cruz M; Link H
    J Infect Dis; 1990 Jun; 161(6):1194-202. PubMed ID: 2345300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparity between serological reactivity to Borrelia burgdorferi and evidence of past disease in a high-risk group.
    Arteaga F; Golightly MG; Garcia Perez A; Barral M; Anda P; Garcia-Monco JC
    Clin Infect Dis; 1998 Nov; 27(5):1210-3. PubMed ID: 9827271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of antibodies to Borrelia burgdorferi in patients with nonspirochetal subacute bacterial endocarditis.
    Kaell AT; Redecha PR; Elkon KB; Golightly MG; Schulman PE; Dattwyler RJ; Kaell DL; Inman RD; Christian CL; Volkman DJ
    Ann Intern Med; 1993 Dec; 119(11):1079-83. PubMed ID: 8239226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of tests for detection of Borrelia burgdorferi sensu lato infection in patients with diagnosed borreliosis.
    Chmielewska-Badora J; Cisak E; Wójcik-Fatla A; Zwoliński J; Buczek A; Dutkiewicz J
    Ann Agric Environ Med; 2006; 13(2):307-11. PubMed ID: 17196006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of guidelines and two-test approach for lyme disease.
    Blaauw AA; van Loon AM; Schellekens JF; Bijlsma JW
    Rheumatology (Oxford); 1999 Nov; 38(11):1121-6. PubMed ID: 10556266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serological screening for Lyme disease in Israel].
    Kletter Y; Berger SA
    Harefuah; 1993 Nov; 125(9):261-3, 328. PubMed ID: 8253415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Lyme-associated uveitis: value of serological testing in a tertiary centre.
    Bernard A; Kodjikian L; Abukhashabh A; Roure-Sobas C; Boibieux A; Denis P; Broussolle C; Seve P
    Br J Ophthalmol; 2018 Mar; 102(3):369-372. PubMed ID: 28659389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an enzyme-linked immunosorbent assay that uses the 41-kd flagellin as the antigen for detection of antibodies to Borrelia burgdorferi in cattle.
    Ji B; Thomas CB; Collins MT
    Am J Vet Res; 1994 Sep; 55(9):1213-9. PubMed ID: 7802386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False positive seroreactivity to Borrelia burgdorferi in systemic lupus erythematosus: the value of immunoblot analysis.
    Weiss NL; Sadock VA; Sigal LH; Phillips M; Merryman PF; Abramson SB
    Lupus; 1995 Apr; 4(2):131-7. PubMed ID: 7795616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of serological testing for Lyme disease in the UK.
    Rees DH; O'Connell S; Brown MM; Robertson J; Axford JS
    Br J Rheumatol; 1995 Feb; 34(2):132-6. PubMed ID: 7704458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid immune complexes in patients exposed to Borrelia burgdorferi: detection of Borrelia-specific and -nonspecific complexes.
    Coyle PK; Schutzer SE; Belman AL; Krupp LB; Golightly MG
    Ann Neurol; 1990 Dec; 28(6):739-44. PubMed ID: 2285261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood donor Borrelia burgdorferi sensu lato seroprevalence and history of tick bites at a northern limit of the vector distribution.
    Hvidsten D; Mortensen L; Straume B; Arsenovic MG; Pedersen AB; Lyngås G; Gray JS; Grude N
    APMIS; 2017 Aug; 125(8):717-724. PubMed ID: 28612350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.